The Pharmacy Times® Neurology Resource Center is a comprehensive resource for clinical news and expert insights on disorders of the nervous system, including multiple sclerosis, Alzheimer disease, migraine, and Parkinson disease.
January 17th 2025
These drugs are set to revolutionize their respective disease states in 2025.
Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment
1.5 Credits / Cardiology, Neurology, Rare Diseases
View More
Navigating Parkinson Disease: Innovative Approaches to Mitigate OFF Episodes
1.0 Credit / Neurology
View More
The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of ...
1.0 Credit / Neurology
View More
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
1.0 Credit / Immunology, Neurology
View More
Exploring Therapeutic Advances for Bipolar Disorder With Mixed Features and Anxious Distress: An Update for Ph...
2.0 Credits / Neurology, Psychiatry
View More
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
1 Credit / Cardiology, Neurology
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Setti...
1.25 Credits / Neurology
View More
Addressing the Unmet Needs in the Management of Myasthenia Gravis: The Role of New and Emerging Therapies
1.5 Credits / Neurology
View More
In-Depth Insights and Application in the Management of Immunoglobulin Therapy
1.0 Credit / Neurology, Immunology
View More
Overview and Burden of Migraine
0.5 Credit / Neurology
View More
The Evolving Treatment Landscape of Migraine
0.5 Credit / Neurology
View More
The Role of the Pharmacist Migraine Management
0.5 Credit / Neurology
View More
Significant research progress occurred in 2014, offering new leads that are driving efforts to stop MS, restore function lost, and end MS forever. Here is a brief summary of the research highlights reflecting the Society's commitment to pursue promising opportunities wherever they exist, while focusing on three priority areas: progressive MS, nervous system repair, and wellness/lifestyle, which have been singled out under each research goal below when applicable.
Read More
Noted film and TV star Madeleine Stowe brings a new and personal awareness to the MS movement
December 3rd 2014Activist and award-winning actress Madeleine Stowe recently went public about her late father's battle with multiple sclerosis, revealing to fans that she's nothing like the scheming Victoria Grayson who she portrays on ABC's hit show "Revenge." And this winter, Stowe will continue to share her inspiring story and insights about growing up in a family impacted by MS as she embarks on a tour across the country to meet people living with MS who will likewise share their experiences with the disease. The events will feature leading neurologists, lifestyle experts and people living with MS who are taking action in their own unique ways.
Read More
Complex Jobs May Aid Cognitive Abilities Later in Life
November 24th 2014What do lawyers and social workers have in common? According to a new study published in Neurology, these 2 kinds of workers may perform better on cognitive testing in their later years compared with those working in less stimulating jobs.
Read More
From Architect to Social Worker: Complex Jobs May Protect Memory and Thinking
November 20th 2014People whose jobs require more complex work with other people, such as social workers and lawyers, or with data, like architects or graphic designers, may end up having longer-lasting memory and thinking abilities compared to people who do less complex work.
Read More
Panobinostat Combination Therapy in Multiple Myeloma: Interim Results from PANORAMA
September 28th 2014Adding panobinostat to a combination treatment of bortezomib and dexamethasone in heavily pretreated patients boosts progression-free survival, but overall survival data are not yet mature.
Read More